In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

Hayfever formulary change May 2019

 HAY FEVER FORMULARY UPDATE FOR 2019


The CAS hay fever module has been revised to enable users to supply more than one month’s treatment during a consultation.
 
Users should use professional discretion when supplying treatment and use the following as guidance:
  1. The initial supply should be for month’s treatment to ensure the patient is reviewed for symptom control/adverse effects
  2. Subsequent supplies (or where the patient is already stabilised on treatment) can be for a duration of up to 3 months where clinically appropriate.
  3. Children prescribed steroid nasal sprays must be reviewed frequently (See formulary for further guidance).
  4. All patients should be encouraged to self-care where future treatment may be required as appropriate.
 
The new maximum number of packs that can be supplied are:
 
Product Pack size Maximum number of packs per supply
Cetirizine 10 mg tablets 30 3
Cetirizine 1 mg/ml sugar-free oral solution 200 ml 4
Loratadine 10 mg tablets 30 3
Loratadine 1 mg/ml oral solution 100 ml 4
Chlorphenamine 4 mg tablets 28 3
Chlorphenamine 2 mg/5 ml sugar-free oral solution 150 ml 3
Sodium cromoglicate 2% eye drops 13.5 ml (via PGD) 3
Beclometasone 50 microgram nasal spray 200 spray unit (via PGD) 3